ReproCELL Incorporated (TYO:4978)
Japan flag Japan · Delayed Price · Currency is JPY
104.00
-2.00 (-1.89%)
Nov 18, 2026, 10:23 AM JST

ReproCELL Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
2,4152,2332,9772,4262,9532,234
Other Revenue
--1---
2,4152,2332,9782,4262,9532,234
Revenue Growth
-8.24%-25.02%22.75%-17.85%32.18%73.72%
Cost of Revenue
1,2191,2181,3301,3061,8121,431
Gross Profit
1,1961,0151,6481,1201,141803
Selling, General & Admin
1,2681,2221,2261,129984895
Research & Development
713627536384501535
Amortization of Goodwill & Intangibles
222222
Operating Expenses
2,0071,8751,7791,5301,4971,450
Operating Income
-811-860-131-410-356-647
Interest & Investment Income
108876751889
Earnings From Equity Investments
-4-27-20-3-3-54
Currency Exchange Gain (Loss)
9510917882120
Other Non Operating Income (Expenses)
196110112314129164
EBT Excluding Unusual Items
-416-5814540-121-508
Gain (Loss) on Sale of Investments
----9-52-
Asset Writedown
-6-6--55-131-66
Other Unusual Items
----5--
Pretax Income
-422-58745-29-304-574
Income Tax Expense
24-58211
Earnings From Continuing Operations
-424-591103-31-305-575
Net Income
-424-591103-31-305-575
Net Income to Common
-424-591103-31-305-575
Net Income Growth
------
Shares Outstanding (Basic)
979593868476
Shares Outstanding (Diluted)
979593868476
Shares Change
2.23%1.99%8.45%1.65%10.90%6.32%
EPS (Basic)
-4.39-6.241.11-0.36-3.62-7.57
EPS (Diluted)
-4.39-6.241.11-0.36-3.62-7.57
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-461-481-80-182-291-290
Free Cash Flow Per Share
-4.77-5.08-0.86-2.13-3.46-3.82
Gross Margin
49.52%45.45%55.34%46.17%38.64%35.94%
Operating Margin
-33.58%-38.51%-4.40%-16.90%-12.06%-28.96%
Profit Margin
-17.56%-26.47%3.46%-1.28%-10.33%-25.74%
Free Cash Flow Margin
-19.09%-21.54%-2.69%-7.50%-9.85%-12.98%
EBITDA
-730-786-82-374-308-588
EBITDA Margin
-30.23%-35.20%-2.75%-15.42%-10.43%-26.32%
D&A For EBITDA
817449364859
EBIT
-811-860-131-410-356-647
EBIT Margin
-33.58%-38.51%-4.40%-16.90%-12.06%-28.96%